Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
12
Added to
7
Trimmed
17
Exited
14
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $15.27B across 115 positions in their Q3 2022 SEC 13F filing (period ending 2022-09-30). The top 10 positions account for 84.7% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | SGENUSDSeagen Inc. | $6.42B | 42.04% | - |
| 2 | INCYIncyte Corporation | $2.41B | 15.78% | +0.0% |
| 3 | ONCBeiGene, Ltd. | $1.57B | 10.30% | - |
| 4 | ACADACADIA Pharmaceuticals Inc. | $685.87M | 4.49% | - |
| 5 | BMRNBioMarin Pharmaceutical Inc. | $645.99M | 4.23% | - |
| 6 | ASNDUSDAscendis Pharma A/S | $501.08M | 3.28% | - |
| 7 | GBTUSDGlobal Blood Therapeutics, Inc. | $254.18M | 1.66% | - |
| 8 | BCRXBioCryst Pharmaceuticals, Inc. | $160.16M | 1.05% | - |
| 9 | RYTMRhythm Pharmaceuticals, Inc. | $148.54M | 0.97% | +47.0% |
| 10 | KODKodiak Sciences Inc. | $133.98M | 0.88% | - |
| Stock | Value | Shares |
|---|---|---|
| CinCor Pharma, Inc. | $26.49M | 807,212 |
| IDYAIDEAYA Biosciences, Inc. | $24.89M | 1,668,355 |
| BCYCBicycle Therapeutics plc | $19.63M | 843,814 |
| VERUEURVeru Inc. | $18.54M | 1,609,579 |
| WHWKAadi Bioscience, Inc. | $13.99M | 989,928 |
| POINT Biopharma Global Inc. | $9.04M | 1,169,103 |
| KRON1USDKronos Bio, Inc. | $5.16M | 1,539,616 |
| FATEFate Therapeutics, Inc. | $4.83M | 215,695 |
| STOKStoke Therapeutics, Inc. | $4.74M | 369,327 |
| CLDNEUREiger BioPharmaceuticals, Inc. | $4.07M | 539,851 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.